Yahoo Finance • last year

Industry Analysts Just Made A Massive Upgrade To Their OptimizeRx Corporation (NASDAQ:OPRX) Revenue Forecasts

OptimizeRx Corporation (NASDAQ:OPRX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to next year's statutory forecasts. The consensus estimated revenue numbers rose, with their view now clearl... Full story

Yahoo Finance • last year

OptimizeRx Reports Third Quarter 2023 Financial Results

- Increases guidance for 2023 and introduces guidance for 2024 - Total revenue of $16.3 million - GAAP net loss per share of $(0.17) - Non-GAAP net income per share of $0.09 - Total DAAP (fka RWD) deals for the year now stands at 16 -... Full story

Yahoo Finance • last year

OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET

WALTHAM, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) a... Full story

Yahoo Finance • last year

OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers

Preannounces Preliminary Third Quarter 2023 Results OptimizeRx adds new, proven, profitable technologies to become the most comprehensive healthcare marketing platform in the nation. Consolidated revenue run rate will increase to nearly... Full story

Yahoo Finance • last year

OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform

WALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) an... Full story

Yahoo Finance • last year

OptimizeRx Expands AI Powered Omnichannel Platform

WALTHAM, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced the expansion of its... Full story

Yahoo Finance • last year

OptimizeRx Reports Second Quarter 2023 Financial Results

– RWD.AI-enabled portion of the core business sees 186% YOY growth during the first half of 2023 – Non-core business is lagging – Total revenue of $13.8 million – GAAP net loss per share of $(0.24) – Non-GAAP net loss per share of $(0.... Full story

Yahoo Finance • 2 years ago

LifeMD Appoints William J. Febbo to its Board of Directors

NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of William (Will) J. Febbo, Chief Executive Officer and Director of OptimizeRx... Full story

Yahoo Finance • 2 years ago

OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100

ROCHESTER, Mich., May 18, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy today announced that Karina Castagna,... Full story

Yahoo Finance • 2 years ago

OptimizeRx to Participate in Upcoming Investor Conferences

ROCHESTER, Mich., May 15, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced that management will... Full story

Yahoo Finance • 2 years ago

OptimizeRx Reports First Quarter 2023 Financial Results

Total revenue of $13.0 millionGAAP net loss per share of $(0.37)Non-GAAP net loss per share of $(0.09) ROCHESTER, Mich., May 10, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-ca... Full story

Yahoo Finance • 2 years ago

Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance

ROCHESTER, Mich., May 02, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced the results of a sur... Full story

Yahoo Finance • 2 years ago

OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET

ROCHESTER, Mich., April 26, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy will hold a conference call on Wedn... Full story

Yahoo Finance • 2 years ago

OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report

ROCHESTER, Mich., April 04, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy has published its 2023 Environmenta... Full story

Yahoo Finance • 2 years ago

Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year

ROCHESTER, Mich., March 29, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, has been named to the Financial Ti... Full story

Yahoo Finance • 2 years ago

OptimizeRx Authorizes $15 Million Share Repurchase Program

ROCHESTER, Mich., March 14, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that its Board of... Full story

Yahoo Finance • 2 years ago

OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients

ROCHESTER, Mich., March 09, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced a multi-million-do... Full story

Yahoo Finance • 2 years ago

OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results

Q4 revenue of $19.7 million, down 3% year-over-year and up 30% quarter-over-quarterQ4 gross profit increased 1% year-over-year to $12.5 million as gross margins increased from 61% to 63%Generated $10.7 million in cash flow from operations... Full story

Yahoo Finance • 2 years ago

OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET

ROCHESTER, Mich., Feb. 23, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, will hold a conference call on Wedn... Full story

Yahoo Finance • 2 years ago

OptimizeRx Reports Third Quarter 2022 Financial Results

Q3 Revenue of $15.1 million, down 6% year-over-year and up 8% quarter-over-quarter Gross profit increased 4% year-over-year to $9.4 million as gross margins increased from 56% to 62%Generated $7.9 million in cash flow from operations durin... Full story